HIGH-DOSE ORAL AND INTRAVENOUS METOCLOPRAMIDE IN DOXORUBICIN CYCLOPHOSPHAMIDE-INDUCED EMESIS - A RANDOMIZED DOUBLE-BLIND-STUDY

被引:17
作者
EDGE, SB
FUNKHOUSER, WK
BERMAN, A
SEIPP, C
TANNER, A
WESLEY, R
ROSENBERG, SA
CHANG, AE
机构
[1] NCI,CTR CLIN,SURG BRANCH,BLDG 10,RM 2B42,BETHESDA,MD 20892
[2] NCI,CTR CLIN,DIV CANC TREATMENT,BETHESDA,MD 20892
[3] NCI,CTR CLIN,DEPT NURSING,BETHESDA,MD 20892
[4] NCI,CTR CLIN,PHARM SERV,BETHESDA,MD 20892
[5] NCI,CTR CLIN,BIOMETR RES BRANCH,BETHESDA,MD 20892
来源
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1987年 / 10卷 / 03期
关键词
D O I
10.1097/00000421-198706000-00020
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:257 / 263
页数:7
相关论文
共 34 条
[1]   DOUBLE-BLIND CROSSOVER STUDY OF THE ANTIEMETIC EFFICACY OF HIGH-DOSE DEXAMETHASONE VERSUS HIGH-DOSE METOCLOPRAMIDE [J].
AAPRO, MS ;
PLEZIA, PM ;
ALBERTS, DS ;
GRAHAM, V ;
JONES, SE ;
SURWIT, EA ;
MOON, TE .
JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (05) :466-471
[2]  
ALAVI JB, 1984, P AN M AM SOC CLIN, V3, P109
[3]  
ANTHONY LB, 1984, P AM SOC CLIN ONCOL, V3, P104
[4]  
BORISON HL, 1983, DRUGS S, V1, P8
[5]   DELTA-9-TETRAHYDROCANNABINOL IN CANCER-CHEMOTHERAPY - RESEARCH PROBLEMS AND ISSUES [J].
CAREY, MP ;
BURISH, TG ;
BRENNER, DE .
ANNALS OF INTERNAL MEDICINE, 1983, 99 (01) :106-114
[6]  
CHANG AE, 1981, CANCER, V47, P1746
[7]   AMELIORATION OF CANCER CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING BY DELTA-9-TETRAHYDROCANNABINOL [J].
EKERT, H ;
WATERS, KD ;
JURK, IH ;
MOBILIA, J ;
LOUGHNAN, P .
MEDICAL JOURNAL OF AUSTRALIA, 1979, 2 (12) :657-659
[8]   ORAL METOCLOPRAMIDE AND CISPLATIN CHEMOTHERAPY [J].
GARNICK, MB .
ANNALS OF INTERNAL MEDICINE, 1983, 99 (01) :127-127
[9]  
GOSLIN RH, 1981, TREATMENT CANCER CHE, P159
[10]   ANTI-EMETIC EFFICACY OF HIGH-DOSE METOCLOPRAMIDE - RANDOMIZED TRIALS WITH PLACEBO AND PROCHLORPERAZINE IN PATIENTS WITH CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING [J].
GRALLA, RJ ;
ITRI, LM ;
PISKO, SE ;
SQUILLANTE, AE ;
KELSEN, DP ;
BRAUN, DW ;
BORDIN, LA ;
BRAUN, TJ ;
YOUNG, CW .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (16) :905-909